EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2

Takuto Inoki, Akito Tsuruta, Yoshinori Masakado, Yuichiro Kai, Yuya Yoshida, Naoya Matsunaga, Shigehiro Ohdo, Satoru Koyanagi

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.108544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Takuto Inoki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, RNA Stability, RNA, Messenger. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Science and Technology Agency, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common and aggressive form of malignant brain cancer, with a poor prognosis and a 5-year survival rate of approximately 15%. The malignancy of GBM, including its treatment resistance and high recurrence rate, is largely attributed to the presence of cancer stem cells. Recent studies have identified the N-acetyltransferase 10 (NAT10), an enzyme responsible for catalyzing N4-acetylcytidine (ac4C) modification in RNA, as a key factor in cancer biology, with diverse roles across multiple cancer types. However, the specific contribution of this RNA modification to the malignancy of GBM remains unexplored. Here, we demonstrate that NAT10 expression is associated with poor prognosis in GBM patients and that NAT10 promotes GBM malignancy by enhancing stemness properties in human GBM cell line U251 and A172. A search for the underlying mechanism of NAT10-mediated enhancement of GBM stemness led to identification of polycomb repressive complex 2 (PRC2)-related genes as an epigenetic regulator. NAT10 mediates the acetylation of the coding region of Jumonji and AT-rich Interaction Domain containing 2 (JARID2) mRNA, which results in increased mRNA stability and elevated protein levels. Notably, the knockdown of JARID2 significantly reduced GBM stemness, suppressed tumor growth, and extended the survival of xenograft mice. Our findings suggest that NAT10-mediated acetylation of JARID2 mRNA up-regulates its protein levels, thereby promoting stemness and contributing to the malignancy of GBM. Targeting this NAT10-JARID2 axis may represent a novel therapeutic approach for treatment of GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsRNA StabilityRNA, MessengerN-Terminal Acetyltransferase EJumonji Domain-Containing Histone DemethylasesHumansAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticNeoplastic Stem CellsMice, NudeAcetylationN-Terminal Acetyltransferases

Stichwörter der Autor:innen

JARID2NAT10RNA acetylationcancer stem cellsglioblastoma

Substanzen

NAT10 protein, humanRNA, MessengerN-Terminal Acetyltransferase EJumonji Domain-Containing Histone DemethylasesN-Terminal Acetyltransferases

Autor:innen und Institutionen

  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences Kyushu University, Higashi-ku, Fukuoka, Japan.
  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences Kyushu University, Higashi-ku, Fukuoka, Japan. Electronic address: ohdo@phar.kyushu-u.ac.jp.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. Electronic address: koyanagi@phar.kyushu-u.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science
  • Fukuoka Public Health Promotion Organization Cancer Research Fund
  • Kyushu University

Zitieren

APA

Inoki, T., Tsuruta, A., Masakado, Y., Kai, Y., Yoshida, Y., Matsunaga, N., Ohdo, S., & Koyanagi, S. (2025). N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108544

Vancouver

Inoki T, Tsuruta A, Masakado Y, Kai Y, Yoshida Y, Matsunaga N, et al. N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108544

BibTeX
@article{Inoki2025,
  author = {Inoki, Takuto and Tsuruta, Akito and Masakado, Yoshinori and Kai, Yuichiro and Yoshida, Yuya and Matsunaga, Naoya and Ohdo, Shigehiro and Koyanagi, Satoru},
  title = {N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.108544}
}
Kostenlos starten →